Bisphosphonate nephropathy: A case series and review of the literature
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bisphosphonate nephropathy: A case series and review of the literature
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-18
DOI
10.1111/bcp.14780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
- (2017) Takashi Shigematsu et al. BMC Nephrology
- Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States
- (2017) Yi Qian et al. Cancer Medicine
- Treatment of osteoporosis in renal insufficiency
- (2015) Lydia G. Schipper et al. CLINICAL RHEUMATOLOGY
- Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy
- (2015) R. Bergner et al. PHARMACOLOGICAL RESEARCH
- The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women
- (2015) Barry S Komm et al. Expert Review of Clinical Pharmacology
- Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project
- (2013) Beatrice J. Edwards et al. Journal of Oncology Practice
- Oral bisphosphonate use in the elderly is not associated with acute kidney injury
- (2012) Andrew W.Y. Shih et al. KIDNEY INTERNATIONAL
- Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis
- (2012) M. Yilmaz et al. OSTEOPOROSIS INTERNATIONAL
- Management of Osteoporosis in CKD Stages 3 to 5
- (2010) Patricia L. Gordon et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy
- (2010) Allan Lipton SEMINARS IN ONCOLOGY
- Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis
- (2008) Naoto Miura et al. Clinical and Experimental Nephrology
- Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women
- (2008) Steven Boonen et al. KIDNEY INTERNATIONAL
- Bisphosphonate nephrotoxicity
- (2008) Mark A. Perazella et al. KIDNEY INTERNATIONAL
- Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review
- (2008) Ingo J. Diel et al. SUPPORTIVE CARE IN CANCER
- Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: Implications for renal safety
- (2008) Anke Lühe et al. TOXICOLOGY IN VITRO
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now